Neurotorium
@neurotorium.org
At Neurotorium, our mission is to improve awareness and knowledge about the brain and its diseases. Neurotorium.org is a non-commercial, non-profit initiative founded by the Lundbeck Foundation.
New deck: Anxiety - Comorbidities. Comorbidity is common. Anxiety often co-occurs with other mental disorders and with medical illnesses - complicating diagnosis & treatment and highlighting the need for early, integrated care.
https://neurotorium.org/slidedeck/anxiety-disorders-comorbidities/
https://neurotorium.org/slidedeck/anxiety-disorders-comorbidities/
November 14, 2025 at 9:00 AM
New deck: Anxiety - Comorbidities. Comorbidity is common. Anxiety often co-occurs with other mental disorders and with medical illnesses - complicating diagnosis & treatment and highlighting the need for early, integrated care.
https://neurotorium.org/slidedeck/anxiety-disorders-comorbidities/
https://neurotorium.org/slidedeck/anxiety-disorders-comorbidities/
New deck: Anxiety - Treatment Principles. Covers psychological & pharmacological therapies, disorder-specific CBT models, current pharmacologic options, predictors of response, combination strategies, and emerging treatments.
https://neurotorium.org/slidedeck/anxiety-disorders-treatment-principles/
https://neurotorium.org/slidedeck/anxiety-disorders-treatment-principles/
November 12, 2025 at 9:00 AM
New deck: Anxiety - Treatment Principles. Covers psychological & pharmacological therapies, disorder-specific CBT models, current pharmacologic options, predictors of response, combination strategies, and emerging treatments.
https://neurotorium.org/slidedeck/anxiety-disorders-treatment-principles/
https://neurotorium.org/slidedeck/anxiety-disorders-treatment-principles/
New deck: Anxiety - Neurobiology & Aetiology. From fear circuits to conditioning/extinction and biomarkers: what drives symptoms and why exposure works. Imaging, genetics, interoception, gut–brain, sex differences.
https://neurotorium.org/slidedeck/anxiety-disorders-neurobiology-and-aetiology/
https://neurotorium.org/slidedeck/anxiety-disorders-neurobiology-and-aetiology/
November 10, 2025 at 9:00 AM
New deck: Anxiety - Neurobiology & Aetiology. From fear circuits to conditioning/extinction and biomarkers: what drives symptoms and why exposure works. Imaging, genetics, interoception, gut–brain, sex differences.
https://neurotorium.org/slidedeck/anxiety-disorders-neurobiology-and-aetiology/
https://neurotorium.org/slidedeck/anxiety-disorders-neurobiology-and-aetiology/
New deck: Anxiety - Course & Prognosis. Covers studies examining remission, relapse, and recurrence, as well as predictors of the course of anxiety.
Explore here:
https://neurotorium.org/slidedeck/anxiety-disorders-course-natural-history-and-prognosis/
Explore here:
https://neurotorium.org/slidedeck/anxiety-disorders-course-natural-history-and-prognosis/
November 7, 2025 at 9:00 AM
New deck: Anxiety - Course & Prognosis. Covers studies examining remission, relapse, and recurrence, as well as predictors of the course of anxiety.
Explore here:
https://neurotorium.org/slidedeck/anxiety-disorders-course-natural-history-and-prognosis/
Explore here:
https://neurotorium.org/slidedeck/anxiety-disorders-course-natural-history-and-prognosis/
New slide deck: Anxiety - Epidemiology & Burden. Covers recent research into prevalence rates of different anxiety disorders, comorbidities, as well as the individual and economic burden of anxiety disorders.
Explore here: https://neurotorium.org/slidedeck/anxiety-disorders-epidemiology-and-burden/
Explore here: https://neurotorium.org/slidedeck/anxiety-disorders-epidemiology-and-burden/
November 5, 2025 at 9:00 AM
New slide deck: Anxiety - Epidemiology & Burden. Covers recent research into prevalence rates of different anxiety disorders, comorbidities, as well as the individual and economic burden of anxiety disorders.
Explore here: https://neurotorium.org/slidedeck/anxiety-disorders-epidemiology-and-burden/
Explore here: https://neurotorium.org/slidedeck/anxiety-disorders-epidemiology-and-burden/
New slide deck: Anxiety Disorders - History, Definitions & Diagnosis. Covers major manual updates, clinical features, staging, validated scales, and differential diagnosis.
Explore here:
https://neurotorium.org/slidedeck/anxiety-disorders-history-definitions-and-diagnosis/
Explore here:
https://neurotorium.org/slidedeck/anxiety-disorders-history-definitions-and-diagnosis/
November 3, 2025 at 9:00 AM
New slide deck: Anxiety Disorders - History, Definitions & Diagnosis. Covers major manual updates, clinical features, staging, validated scales, and differential diagnosis.
Explore here:
https://neurotorium.org/slidedeck/anxiety-disorders-history-definitions-and-diagnosis/
Explore here:
https://neurotorium.org/slidedeck/anxiety-disorders-history-definitions-and-diagnosis/
Don't miss the newest Neurotorium article Brain Insulin Action and Metabolic Dysregulation in Schizophrenia: From Mechanistic Insights to Novel Interventions.
https://neurotorium.org/article/brain-insulin-action-and-metabolic-dysregulation-in-schizophrenia/
https://neurotorium.org/article/brain-insulin-action-and-metabolic-dysregulation-in-schizophrenia/
October 31, 2025 at 9:01 AM
Don't miss the newest Neurotorium article Brain Insulin Action and Metabolic Dysregulation in Schizophrenia: From Mechanistic Insights to Novel Interventions.
https://neurotorium.org/article/brain-insulin-action-and-metabolic-dysregulation-in-schizophrenia/
https://neurotorium.org/article/brain-insulin-action-and-metabolic-dysregulation-in-schizophrenia/
Today is World Stroke Day. We believe stroke awareness and education are essential. With 1 in 4 people at risk, knowing the signs and acting fast can save lives.
Visit https://neurotorium.org/stroke/ to access free educational resources and share the link to support stroke awareness
#WorldStrokeDay
Visit https://neurotorium.org/stroke/ to access free educational resources and share the link to support stroke awareness
#WorldStrokeDay
October 29, 2025 at 9:00 AM
Today is World Stroke Day. We believe stroke awareness and education are essential. With 1 in 4 people at risk, knowing the signs and acting fast can save lives.
Visit https://neurotorium.org/stroke/ to access free educational resources and share the link to support stroke awareness
#WorldStrokeDay
Visit https://neurotorium.org/stroke/ to access free educational resources and share the link to support stroke awareness
#WorldStrokeDay
Virtual reality exposure therapy shows outcomes comparable to traditional in-vivo exposure, offering new opportunities for scalable, individualized anxiety treatments.
Read the full overview on:
🔗 https://neurotorium.org/article/virtual-reality-in-anxiety-an-overview/
#AnxietyDisorders #VR
Read the full overview on:
🔗 https://neurotorium.org/article/virtual-reality-in-anxiety-an-overview/
#AnxietyDisorders #VR
October 27, 2025 at 9:00 AM
Virtual reality exposure therapy shows outcomes comparable to traditional in-vivo exposure, offering new opportunities for scalable, individualized anxiety treatments.
Read the full overview on:
🔗 https://neurotorium.org/article/virtual-reality-in-anxiety-an-overview/
#AnxietyDisorders #VR
Read the full overview on:
🔗 https://neurotorium.org/article/virtual-reality-in-anxiety-an-overview/
#AnxietyDisorders #VR
We’re live at #WASAD2025 in Munich!
Come visit the Neurotorium booth to explore our brand-new Anxiety Disorders theme — free, expert-developed materials for clinicians, researchers & students.
🔗 neurotorium.org/anxiety
Come visit the Neurotorium booth to explore our brand-new Anxiety Disorders theme — free, expert-developed materials for clinicians, researchers & students.
🔗 neurotorium.org/anxiety
October 23, 2025 at 11:15 AM
We’re live at #WASAD2025 in Munich!
Come visit the Neurotorium booth to explore our brand-new Anxiety Disorders theme — free, expert-developed materials for clinicians, researchers & students.
🔗 neurotorium.org/anxiety
Come visit the Neurotorium booth to explore our brand-new Anxiety Disorders theme — free, expert-developed materials for clinicians, researchers & students.
🔗 neurotorium.org/anxiety
Anxiety disorders are now among the top 10 global health burdens - with prevalence rising by 50% over the past decade, affecting over 10% of the population.
In this video, Prof. Brenda Penninx discusses what the data reveal.
🎥 Watch here: https://neurotorium.org/video/growing-burden-of-anxiety/
In this video, Prof. Brenda Penninx discusses what the data reveal.
🎥 Watch here: https://neurotorium.org/video/growing-burden-of-anxiety/
October 21, 2025 at 8:00 AM
Anxiety disorders are now among the top 10 global health burdens - with prevalence rising by 50% over the past decade, affecting over 10% of the population.
In this video, Prof. Brenda Penninx discusses what the data reveal.
🎥 Watch here: https://neurotorium.org/video/growing-burden-of-anxiety/
In this video, Prof. Brenda Penninx discusses what the data reveal.
🎥 Watch here: https://neurotorium.org/video/growing-burden-of-anxiety/
Neurotorium brought together world-leading experts from psychiatry and neurology for an extraordinary expert meeting on Advances in Cognition in Brain Disorders, held October 9-10, 2025, in Amsterdam.
Thank you to all participating experts who made this unprecedented gathering exceptional.
Thank you to all participating experts who made this unprecedented gathering exceptional.
October 17, 2025 at 9:21 AM
Neurotorium brought together world-leading experts from psychiatry and neurology for an extraordinary expert meeting on Advances in Cognition in Brain Disorders, held October 9-10, 2025, in Amsterdam.
Thank you to all participating experts who made this unprecedented gathering exceptional.
Thank you to all participating experts who made this unprecedented gathering exceptional.
We're excited to be attending the WASAD Congress next week in Munich, where we'll be showcasing our new Anxiety Disorders theme.
Visit our booth to learn more about Neurotorium’s free expert-developed educational material!
https://neurotorium.org/outreach/activities/
Visit our booth to learn more about Neurotorium’s free expert-developed educational material!
https://neurotorium.org/outreach/activities/
October 16, 2025 at 8:00 AM
We're excited to be attending the WASAD Congress next week in Munich, where we'll be showcasing our new Anxiety Disorders theme.
Visit our booth to learn more about Neurotorium’s free expert-developed educational material!
https://neurotorium.org/outreach/activities/
Visit our booth to learn more about Neurotorium’s free expert-developed educational material!
https://neurotorium.org/outreach/activities/
Many patients with anxiety disorders don’t respond fully to current drugs. New research highlights emerging treatments - from psychedelics to neuropeptide modulators - that may improve outcomes.
Read more: https://neurotorium.org/article/emerging-pharmacological-treatments-for-anxiety-disorders/
Read more: https://neurotorium.org/article/emerging-pharmacological-treatments-for-anxiety-disorders/
October 14, 2025 at 8:00 AM
Many patients with anxiety disorders don’t respond fully to current drugs. New research highlights emerging treatments - from psychedelics to neuropeptide modulators - that may improve outcomes.
Read more: https://neurotorium.org/article/emerging-pharmacological-treatments-for-anxiety-disorders/
Read more: https://neurotorium.org/article/emerging-pharmacological-treatments-for-anxiety-disorders/
10 October is World Mental Health Day - a reminder that there’s no health without mental health. Understanding how our brains work equips us to better support mental health. Every conversation about mental health benefits from scientific understanding.
Explore https://neurotorium.org/themes/
Explore https://neurotorium.org/themes/
October 10, 2025 at 8:00 AM
10 October is World Mental Health Day - a reminder that there’s no health without mental health. Understanding how our brains work equips us to better support mental health. Every conversation about mental health benefits from scientific understanding.
Explore https://neurotorium.org/themes/
Explore https://neurotorium.org/themes/
What if you could ask your questions on bipolar disorder directly to experts?
Join the Neurotorium's Campfire Session, “Precision medicine and measurement-based care in bipolar disorder,” at the 38th ECNP Congress on Sunday, 12 October, 13:55 CET.
neurotorium.org/outreach/act...
@ecnp.eu
Join the Neurotorium's Campfire Session, “Precision medicine and measurement-based care in bipolar disorder,” at the 38th ECNP Congress on Sunday, 12 October, 13:55 CET.
neurotorium.org/outreach/act...
@ecnp.eu
October 8, 2025 at 7:16 AM
What if you could ask your questions on bipolar disorder directly to experts?
Join the Neurotorium's Campfire Session, “Precision medicine and measurement-based care in bipolar disorder,” at the 38th ECNP Congress on Sunday, 12 October, 13:55 CET.
neurotorium.org/outreach/act...
@ecnp.eu
Join the Neurotorium's Campfire Session, “Precision medicine and measurement-based care in bipolar disorder,” at the 38th ECNP Congress on Sunday, 12 October, 13:55 CET.
neurotorium.org/outreach/act...
@ecnp.eu
Now live: our Anxiety theme - 6 expert-reviewed slide decks (200+ slides), 2 articles, 9 videos & 30+ figures. All free - no sign-up required. Explore here: neurotorium.org/anxiety/
October 2, 2025 at 1:36 PM
Now live: our Anxiety theme - 6 expert-reviewed slide decks (200+ slides), 2 articles, 9 videos & 30+ figures. All free - no sign-up required. Explore here: neurotorium.org/anxiety/
Treatment-resistant depression (TRD) represents a significant clinical challenge, affecting approximately 30% of individuals with major depressive disorder (MDD) who fail to respond to at least two adequate antidepressant trials.
Read Neurotorium's article via: neurotorium.org/article/trea...
Read Neurotorium's article via: neurotorium.org/article/trea...
September 30, 2025 at 9:32 AM
Treatment-resistant depression (TRD) represents a significant clinical challenge, affecting approximately 30% of individuals with major depressive disorder (MDD) who fail to respond to at least two adequate antidepressant trials.
Read Neurotorium's article via: neurotorium.org/article/trea...
Read Neurotorium's article via: neurotorium.org/article/trea...
1 week to go!
Next week we're launching our latest theme: Anxiety.
Sign up to be the first to know about our free and open-access slide decks, articles, figures, and videos - all rigorously developed and reviewed by world-leading subject-matter experts.
neurotorium.org/sign-up/
#anxiety
Next week we're launching our latest theme: Anxiety.
Sign up to be the first to know about our free and open-access slide decks, articles, figures, and videos - all rigorously developed and reviewed by world-leading subject-matter experts.
neurotorium.org/sign-up/
#anxiety
September 25, 2025 at 7:55 AM
1 week to go!
Next week we're launching our latest theme: Anxiety.
Sign up to be the first to know about our free and open-access slide decks, articles, figures, and videos - all rigorously developed and reviewed by world-leading subject-matter experts.
neurotorium.org/sign-up/
#anxiety
Next week we're launching our latest theme: Anxiety.
Sign up to be the first to know about our free and open-access slide decks, articles, figures, and videos - all rigorously developed and reviewed by world-leading subject-matter experts.
neurotorium.org/sign-up/
#anxiety
At Neurotorium, our mission is to improve awareness and knowledge of the brain and its diseases through freely accessible, expert-developed educational materials.
Learn more: neurotorium.org/about/
@lundbeckfonden.bsky.social
Learn more: neurotorium.org/about/
@lundbeckfonden.bsky.social
September 23, 2025 at 9:19 AM
At Neurotorium, our mission is to improve awareness and knowledge of the brain and its diseases through freely accessible, expert-developed educational materials.
Learn more: neurotorium.org/about/
@lundbeckfonden.bsky.social
Learn more: neurotorium.org/about/
@lundbeckfonden.bsky.social
World Alzheimer's Day is September 21.
Alzheimer’s disease is the most common cause of dementia in people aged over 65, with ~55 million people living with dementia worldwide in 2020, which is projected to reach ~139 million by 2050.
@alzassociation.bsky.social
Alzheimer’s disease is the most common cause of dementia in people aged over 65, with ~55 million people living with dementia worldwide in 2020, which is projected to reach ~139 million by 2050.
@alzassociation.bsky.social
September 19, 2025 at 10:45 AM
World Alzheimer's Day is September 21.
Alzheimer’s disease is the most common cause of dementia in people aged over 65, with ~55 million people living with dementia worldwide in 2020, which is projected to reach ~139 million by 2050.
@alzassociation.bsky.social
Alzheimer’s disease is the most common cause of dementia in people aged over 65, with ~55 million people living with dementia worldwide in 2020, which is projected to reach ~139 million by 2050.
@alzassociation.bsky.social
Delirium is a medical condition characterized by the acute onset of deficits in attention and other aspects of cognition. Due to the complex network of predisposing and precipitating factors, it is often difficult to assign a specific cause of delirium in a patient.
neurotorium.org/slidedeck/ne...
neurotorium.org/slidedeck/ne...
September 16, 2025 at 8:49 AM
Delirium is a medical condition characterized by the acute onset of deficits in attention and other aspects of cognition. Due to the complex network of predisposing and precipitating factors, it is often difficult to assign a specific cause of delirium in a patient.
neurotorium.org/slidedeck/ne...
neurotorium.org/slidedeck/ne...
GBA1 links Gaucher disease & Parkinson’s.
Increasing understanding of GBA1-driven PD pathology has led to promising treatment avenues, including use of virus vectors to deliver glucocerebrosidase to neurons, use of small molecule chaperone proteins, and more.
neurotorium.org/image/gba1-f...
Increasing understanding of GBA1-driven PD pathology has led to promising treatment avenues, including use of virus vectors to deliver glucocerebrosidase to neurons, use of small molecule chaperone proteins, and more.
neurotorium.org/image/gba1-f...
September 11, 2025 at 7:46 AM
GBA1 links Gaucher disease & Parkinson’s.
Increasing understanding of GBA1-driven PD pathology has led to promising treatment avenues, including use of virus vectors to deliver glucocerebrosidase to neurons, use of small molecule chaperone proteins, and more.
neurotorium.org/image/gba1-f...
Increasing understanding of GBA1-driven PD pathology has led to promising treatment avenues, including use of virus vectors to deliver glucocerebrosidase to neurons, use of small molecule chaperone proteins, and more.
neurotorium.org/image/gba1-f...
Don't miss Neurotorium's scientific session on 'Pathways to Precision Psychiatry' at the World Congress of Biological Psychiatry of the WFSBP in Berlin.
Learn more neurotorium.org/outreach/act...
Learn more neurotorium.org/outreach/act...
September 9, 2025 at 11:22 AM
Don't miss Neurotorium's scientific session on 'Pathways to Precision Psychiatry' at the World Congress of Biological Psychiatry of the WFSBP in Berlin.
Learn more neurotorium.org/outreach/act...
Learn more neurotorium.org/outreach/act...
Emotional lability is thought to result from damage to descending brain pathways🧠
Such damage can occur in diseases, including #PD, #ALS, and as a result of #Stroke.
Learn about post-stroke neuropsychiatric symptoms through our educational slide deck: neurotorium.org/slidedeck/ne...
Such damage can occur in diseases, including #PD, #ALS, and as a result of #Stroke.
Learn about post-stroke neuropsychiatric symptoms through our educational slide deck: neurotorium.org/slidedeck/ne...
September 4, 2025 at 11:51 AM
Emotional lability is thought to result from damage to descending brain pathways🧠
Such damage can occur in diseases, including #PD, #ALS, and as a result of #Stroke.
Learn about post-stroke neuropsychiatric symptoms through our educational slide deck: neurotorium.org/slidedeck/ne...
Such damage can occur in diseases, including #PD, #ALS, and as a result of #Stroke.
Learn about post-stroke neuropsychiatric symptoms through our educational slide deck: neurotorium.org/slidedeck/ne...